Immunoclin (Immunoclin) Current Deferred Taxes Liabilities : $0.00 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Immunoclin's current deferred tax liabilities for the quarter that ended in Oct. 2014 was $0.00 Mil.

Immunoclin Current Deferred Taxes Liabilities Historical Data

The historical data trend for Immunoclin's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Current Deferred Taxes Liabilities Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Current Deferred Taxes Liabilities

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Immunoclin's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines